Lee et al., 2001 - Google Patents
Activation of CD14 on circulating monocytes in patients with acute coronary syndromeLee et al., 2001
- Document ID
- 18060566568845024627
- Author
- Lee W
- Lee Y
- Jeong J
- Lee S
- Choi Y
- Park J
- Publication year
- Publication venue
- International journal of cardiology
External Links
Snippet
Background: Increasing evidence supports the involvement of inflammation in acute phase of coronary artery diseases. Methods: We analyzed the status of activation of inflammatory cells in 38 patients with acute coronary syndrome, 14 stable angina patients, and 19 control …
- 102100003268 CD14 0 title abstract description 76
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nagasawa et al. | LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin | |
| Roth et al. | Attenuation of fever and release of cytokines after repeated injections of lipopolysaccharide in guinea‐pigs. | |
| Genth-Zotz et al. | Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure | |
| Scheubel et al. | Age-dependent depression in circulating endothelial progenitor cells inpatients undergoing coronary artery bypass grafting | |
| Rabin et al. | Altered representation of naive and memory CD8 T cell subsets in HIV-infected children. | |
| Nomura et al. | Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus | |
| Pan et al. | MDP-induced interleukin-1β processing requires Nod2 and CIAS1/NALP3 | |
| Liuzzo et al. | Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein: evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation | |
| Yagnik et al. | Macrophage release of transforming growth factor β1 during resolution of monosodium urate monohydrate crystal–induced inflammation | |
| Liu et al. | Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication | |
| Ikejima et al. | Upregulation of fractalkine and its receptor, CX3CR1, is associated with coronary plaque rupture in patients with unstable angina pectoris | |
| Tousoulis et al. | Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure | |
| Devaraj et al. | Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications | |
| Yücel et al. | Interleukin‐11, interleukin‐1β, interleukin‐12 and the pathogenesis of inflammatory periodontal diseases | |
| Haider et al. | C-reactive protein is expressed and secreted by peripheral blood mononuclear cells | |
| Moreaux et al. | Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration | |
| Lieb et al. | No association of interleukin-6 gene polymorphism (− 174 G/C) with myocardial infarction or traditional cardiovascular risk factors | |
| Song et al. | C‐reactive protein contributes to the hypercoagulable state in coronary artery disease | |
| Hasib et al. | Functional and homeostatic defects of regulatory T cells in patients with coronary artery disease | |
| Blank et al. | Circulating dendritic cell number and intracellular TNF-α production in women with type 2 diabetes | |
| Mori et al. | Association of serum TRAIL level with coronary artery disease | |
| Mazur et al. | Lymphocyte and monocyte subpopulations in severe aortic stenosis at the time of surgical intervention | |
| Lichte et al. | Low dose LPS does not increase TLR4 expression on monocytes in a human in vivo model | |
| Justo-Junior et al. | Monocytes of patients with unstable angina express high levels of chemokine and pattern-recognition receptors | |
| Lee et al. | Activation of CD14 on circulating monocytes in patients with acute coronary syndrome |